Back to Results
First PageMeta Content
Sulfonamides / Medicine / Carbamates / Darunavir / HIV/AIDS / Antiretroviral drug / ViiV Healthcare / Zidovudine / Integrase inhibitor / Protease inhibitors / Chemistry / Biology


Data from the FLAMINGO Phase IIIb/IV Study of the Integrase Inhibitor Tivicay® (dolutegravir), Disclosed by ViiV Healthcare Osaka, Japan, September 13, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: I
Add to Reading List

Document Date: 2014-11-03 11:26:11


Open Document

File Size: 31,44 KB

Share Result on Facebook
UPDATE